0001192482-19-000335.txt : 20190813 0001192482-19-000335.hdr.sgml : 20190813 20190813164235 ACCESSION NUMBER: 0001192482-19-000335 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190809 FILED AS OF DATE: 20190813 DATE AS OF CHANGE: 20190813 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brannelly Paul CENTRAL INDEX KEY: 0001394936 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37372 FILM NUMBER: 191021260 MAIL ADDRESS: STREET 1: C/O KARYOPHARM THERAPEUTICS INC. STREET 2: 2 MERCER ROAD CITY: NATICK STATE: MA ZIP: 01760 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COLLEGIUM PHARMACEUTICAL, INC CENTRAL INDEX KEY: 0001267565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 BUSINESS PHONE: 781-713-3699 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY CENTER DRIVE CITY: STOUGHTON STATE: MA ZIP: 02072 FORMER COMPANY: FORMER CONFORMED NAME: COLLEGIUM PHARMACEUTICAL INC DATE OF NAME CHANGE: 20031020 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-08-09 0001267565 COLLEGIUM PHARMACEUTICAL, INC COLL 0001394936 Brannelly Paul C/O COLLEGIUM PHARMACEUTICAL, INC. 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 0 1 0 0 Executive Vice President & CFO Common Stock 2019-07-26 5 A 0 797 9.04 A 152904 D Common Stock 2019-08-09 4 F 0 1517 11.24 D 151387 D Shares acquired under the Collegium Pharmaceutical, Inc. 2015 Employee Stock Purchase Plan in a transaction exempt under both Rule 16b-3(d) and Rule 16b-3(c). Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. /s/ Paul Brannelly 2019-08-13